Reaction
Vessel Puncture Site Bruise reporting signals
As of the last recalculation, Vessel Puncture Site Bruise appears in 195 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 176.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 13 | 176.3 | 176.5 |
| Dalteparin Sodium | 15 | 163.9 | 164.1 |
| Pertuzumab | 14 | 59.1 | 59.2 |